参考文献/References:
［1］ Pateria P， Jeffrey GP， Garas G， et al. Transjugular intrahepatic portosystemic shunt： indications， complications， survival and its use as a bridging therapy to liver transplant in Western Australia［J］. J Med Imaging Radiat Oncol， 2017， 61： 441- 447.
［2］ Trebicka J. Does transjugular intrahepatic portosystemic shunt stent differentially improve survival in a subset of cirrhotic patients?［J］. Semin Liver Dis， 2018， 38：87- 96.
［3］ 刘家成，周 晨，石 钦，等． 临床显著性门静脉高压无创预测［J］． 介入放射学杂志， 2020， 29：521- 526．
［4］ Ascha M， Abuqayyas S， Hanouneh I， et al. Predictors of mortality after transjugular portosystemic shunt［J］. World J Hepatol， 2016， 8： 520- 529.
［5］ Fagiuoli S， Bruno R， Venon WD， et al. Consensus conference on TIPS management： techniques， indications， contraindications［J］. Dig Liver Dis， 2017， 49： 121- 137.
［6］ Sauerbruch T， Mengel M， Dollinger M， et al. Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small- diameter stents versus hemodynamically controlled medical therapy［J］. Gastroenterology， 2015， 149： 660- 668.
［7］ Trebicka J. Emergency TIPS in a Child- Pugh B patient： when does the window of opportunity open and close?［J］. J Hepatol， 2017， 66： 442- 450.
［8］ de Franchis R. Expanding consensus in portal hypertension： report of the baveno vi consensus workshop： stratifying risk and individualizing care for portal hypertension［J］. J Hepatol，2015，63：743- 752.
［9］ Luo X， Wang X， Zhu Y， et al. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with expanded polytetrafluoroethylene- covered stent- grafts： 8- mm versus 10- mm［J］. Cardiovasc Intervent Radiol， 2019， 42： 737- 743.
［10］ Wang Q， Lü Y， Bai M， et al. Eight millimetre covered tips does not compromise shunt function but reduces hepatic encephalo- pathy in preventing variceal rebleeding［J］. J Hepatol， 2017， 67： 508- 516.
［11］ Violi F， Corazza GR， Caldwell SH， et al. Portal vein thrombosis relevance on liver cirrhosis： Italian venous thrombotic events registry［J］. Intern Emerg Med， 2016， 11： 1059- 1066.
［12］ Miraglia R， Maruzzelli L， Tuzzolino F， et al. Transjugular intrahepatic portosystemic shunts in patients with cirrhosis with refractory ascites： comparison of clinical outcomes by using 8- and 10- mm PTFE- covered stents［J］. Radiology， 2017， 284： 281- 288.
［13］ Trebicka J， Bastgen D， Byrtus J， et al. Smaller- diameter covered transjugular intrahepatic portosystemic shunt stents are associated with increased survival［J］. Clin Gastroenterol Hepatol， 2019， 17： 2793- 2799.
［14］ Vilstrup H， Amodio P， Bajaj J， et al. Hepatic encephalopathy in chronic liver disease： 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver［J］. Hepatology， 2014， 60： 715- 735.
［15］ 王 重，刘福全． 经颈静脉肝内门体分流术后肝性脑病的研究进展［J］． 临床肝胆病杂志， 2019， 35：2824- 2827．
［16］ Triantafyllou T， Aggarwal P， Gupta E， et al. Polytetrafluoroe- thylene- covered stent graft versus bare stent in transjugular intrahepatic portosystemic shunt： systematic review and meta- analysis［J］. J Laparoendosc Adv Surg Tech A， 2018， 28： 867- 879.
［17］ Miraglia R， Maruzzelli L， Di Piazza A， et al. Transjugular intrahepatic portosystemic shunt using the new gore viatorr controlled expansion endoprosthesis： prospective， single- center， preliminary experience［J］. Cardiovasc Intervent Radiol， 2019， 42： 78- 86.
［18］ Wang L， Xiao Z， Yue Z， et al. Efficacy of covered and bare stent in tips for cirrhotic portal hypertension：a single- center randomized trial［J］. Sci Rep， 2016， 6：21011.
［19］ Tsauo J， Li X. Viatorr tips endoprosthesis versus generic expanded polytetrafluoroethylene- covered stent- grafts［J］. AJR Am J Roent- genol， 2015， 205： W463.
［20］ 林志鹏，赵剑波，陈斯良． 采用Viatorr覆膜支架建立经颈静脉肝内门体静脉分流术的中期疗效分析［J］．中华肝脏病杂志， 2019， 27：440- 444．
［21］ Saad WE， Darwish WM， Davies MG， et al. Stent- grafts for transjugular intrahepatic portosystemic shunt creation： specialized TIPS stent- graft versus generic stent- graft/bare stent combination［J］. J Vasc Interv Radiol， 2010， 21： 1512- 1520.
［22］ Li Z， Jiao DC， Si G， et al. Use of fenestration to revise shunt dysfunction after transjugular intrahepatic portosystemic shunt［J］. Abdom Radiol（NY）， 2020， 45： 556- 562.
［23］ Gaba RC， Parvinian A， Minocha J， et al. Should transjugular intrahepatic portosystemic shunt stent grafts be underdilated?［J］. J Vasc Interv Radiol， 2015， 26： 382- 387.
［24］ Pieper CC， Jansen C， Meyer C， et al. Prospective evaluation of passive expansion of partially dilated transjugular intrahepatic portosystemic shunt stent grafts：a three- dimensional sonography study［J］. J Vasc Interv Radiol， 2017， 28： 117- 125.
［25］ Mollaiyan A， Bettinger D， Rossle M. The underdilation of nitinol stents at TIPS implantation： solution or illusion?［J］. Eur J Radiol， 2017， 89： 123- 128.
［26］ Srinivasa RN， Srinivasa RN， Chick JF， et al. Transjugular intrahepatic portosystemic shunt reduction using the GORE VIATORR controlled expansion endoprosthesis： hemodynamics of reducing an established 10- mm TIPS to 8- mm in diameter［J］. Cardiovasc Intervent Radiol， 2018， 41： 518- 521.
［27］ Cui J， Smolinski SE， Liu F， et al. Incrementally expandable transjugular intrahepatic portosystemic shunts： single- center experience［J］. AJR Am J Roentgenol， 2018， 210： 438- 446.
［28］ Praktiknjo M， Lehmann J， Fischer S， et al. Novel diameter controlled expansion TIPS Viatorr CX graft reduces readmission compared to regular covered TIPS GRAFT and bare metal graft［J］. J Hepatol， 2017， 66（Suppl）：S48- S49.
［29］ Clark TW， Agarwal R， Haskal ZJ， et al. The effect of initial shunt outflow position on patency of transjugular intrahepatic portosys-temic shunts［J］. J Vasc Interv Radiol， 2004， 15： 147- 152.
［30］ Richard J， Thornburg B. New techniques and devices in transjugular intrahepatic portosystemic shunt placement［J］. Semin Intervent Radiol， 2018， 35： 206- 214.
［31］ Bai M， He CY， Qi XS， et al. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt［J］. World J Gastroenterol， 2014， 20： 774- 785.
［32］ Luo SH， Chu JG， Huang H， et al. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy［J］. World J Gastroenterol， 2019， 25： 1088- 1099.
［33］ Chen SL，Hu P，Lin ZP，et al. The effect of puncture sites of portal vein in tips with eptfe- covered stents on postoperative long- term clinical efficacy［J］. Gastroenterol Res Pract， 2019， 2019：2935498.
［34］ 苗同国，褚建国，黄 鹤，等． 经颈静脉肝内门静脉左支门体分流中支架位置对远期疗效的影响［J］． 介入放射学杂志， 2017，26：299- 302．
［35］ Luo SH， Chu JG， Huang H， et al. Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt［J］. World J Gastroenterol， 2017， 23： 4779- 4787.
［36］ Miyamoto R， Inagawa S， Nagai K， et al. Three- dimensional reconstruction of vascular arrangement including the hepatic artery and left gastric vein during gastric surgery［J］. Springerplus， 2016， 5： 835.
［37］ Gill AB， Hilliard NJ， Hilliard ST， et al. A semi- automatic method for the extraction of the portal venous input function in quantitative dynamic contrast- enhanced CT of the liver［J］. Br J Radiol， 2017， 90： 20160875.
相似文献/References:
[1]谢苏庆,许国铭.治疗门脉高压的新途径——经颈静脉肝内门体分流术[J].介入放射学杂志,1994,(02):116.
[2]陈云燕.TIPSS的并发症[J].介入放射学杂志,1994,(03):174.
[3]祖茂衡,徐浩,顾玉明,等.血管内支架放置治疗下腔静脉闭塞伴血栓形成[J].介入放射学杂志,1995,(04):195.
[4]王永杰,王洪明,王向阳,等.血管内支架置入术治疗下腔静脉阻塞[J].介入放射学杂志,1995,(04):198.
[5]金惠根,王肖龙,陆志刚,等.冠脉内支架在冠脉病变中的应用价值[J].介入放射学杂志,1999,(02):12.
[6]徐仲英.地塞米松血管内支架影响内膜增生的实验研究[J].介入放射学杂志,2000,(02):98.
[7]黄连军,蒋世良,赵世华,等.JOSTENT支架在治疗主动脉及外周动脉狭窄疾患中的应用[J].介入放射学杂志,2000,(02):73.
[8]何仕诚,滕皋军,郭金和,等.自制Palmaz支架的动物实验研究[J].介入放射学杂志,2000,(03):174.
[9]刘增品,赵林,王铁刚,等.颅内静脉窦狭窄支架成型术一例[J].介入放射学杂志,2006,(01):63.
LIU Zeng-pin,ZHAO Lin,WANG Tie-gang,et al.Endovascular stenting for intracranial venous stenosis（a report of 1 case）[J].journal interventional radiology,2006,(09):63.
[10]纪东华,王峰,李城,等.经肝胃造瘘胃肠道支架成形术[J].介入放射学杂志,2006,(03):160.
JI Dong-hua,WANG Feng,LI Cheng,et al.Gastrointestinal stenting：transhepatic and gastrostomy pathways[J].journal interventional radiology,2006,(09):160.